Literature DB >> 30701786

Prognostic factors in IUI.

Gulam Bahadur1,2, Roy Homburg2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30701786      PMCID: PMC6364273          DOI: 10.5935/1518-0557.20180075

Source DB:  PubMed          Journal:  JBRA Assist Reprod        ISSN: 1517-5693


× No keyword cloud information.
Dear Editor, Prognostic factors in IUI analyses is a subject both topical and of importance if pregnancy rates in IUI are to be improved. Although the recent retrospective study (Sicchieri ) aims to decipher the various contributors to IUI pregnancy rates, such as patient age, cause of infertility, ovulation induction method, number of mature follicles and sperm with progressive motility, the overall pregnancy rate of 7.59%/cycle was disappointing and this may give a wrong perception of IUI practice. The UK IUI pregnancy rates averaged around 13.5%/cycle and some clinics exceeding 20%/cycle. It also means that with every 100 women seeking first line treatment as IUI, 25-35% of the cohort will become pregnant (Bahadur a). We even demonstrated how it was possible to overcome the severe oligozoospermic effect by utilising a consecutive ejaculate (Bahadur ). Crucial to IUI success was to switch over to gonadotropin stimulated cycles, aiming for 2-3 follicles, but with a strict cancellation policy to protect the patient from OHSS and multiple births. In more complex and older patients, combination stimulation regimes can be tried. The cost-effective data clearly shows that more pregnancies can occur with gonadotropin stimulated cycles (Peeraer ), or where greater than 3 million motile progressive sperm are inseminated. Newer, well-constructed RCT's provide further strong support for using IUI as first treatment option based on high-quality evidence (Bensdorp ; Farquhar ; Nandi ). Sicchieri et al. (2018) rightly draw attention to affordability issues in most parts of the world, and we now know that over 50% of women undergoing IVF do not need IVF (Malchau ). The way forward is to achieve IUI pregnancies earlier, paying attention to numerous prognostic factors and tailoring the stimulation method for IUI. In particular, these are associated with the use of gonadotrophin stimulation, having greater than 3 million motile progressive sperm in the insemination, having 2-3 follicles, and above all ensuring safe practice against OHSS and multiple births with a strict cancellation policy in place. Secondly, clinics should monitor their outcomes in real time using a dedicated database. Our proposals should help steer the global use of IUI towards a more effective and efficient first line treatment option.
  8 in total

1.  Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial.

Authors:  Anupa Nandi; Priya Bhide; Richard Hooper; Anil Gudi; Amit Shah; Khalid Khan; Roy Homburg
Journal:  Fertil Steril       Date:  2017-05-10       Impact factor: 7.329

2.  Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial.

Authors:  Cynthia M Farquhar; Emily Liu; Sarah Armstrong; Nicola Arroll; Sarah Lensen; Julie Brown
Journal:  Lancet       Date:  2017-11-23       Impact factor: 79.321

3.  First line fertility treatment strategies regarding IUI and IVF require clinical evidence.

Authors:  G Bahadur; R Homburg; A Muneer; P Racich; T Alangaden; A Al-Habib; S Okolo
Journal:  Hum Reprod       Date:  2016-04-12       Impact factor: 6.918

4.  The long-term prognosis for live birth in couples initiating fertility treatments.

Authors:  S S Malchau; A A Henningsen; A Loft; S Rasmussen; J Forman; A Nyboe Andersen; A Pinborg
Journal:  Hum Reprod       Date:  2017-07-01       Impact factor: 6.918

5.  Cost-effectiveness of ovarian stimulation with gonadotrophin and clomiphene citrate in an intrauterine insemination programme for subfertile couples.

Authors:  Karen Peeraer; Jeroen Luyten; Carla Tomassetti; Sarah Verschueren; Carl Spiessens; Ann Tanghe; Christel Meuleman; Sophie Debrock; Eline Dancet; Thomas D'Hooghe
Journal:  Reprod Biomed Online       Date:  2017-12-27       Impact factor: 3.828

6.  Factors Leading to Pregnancies in Stimulated Intrauterine Insemination Cycles and the Use of Consecutive Ejaculations Within a Small Clinic Environment.

Authors:  Gulam Bahadur; Ofran Almossawi; Afeeza IIlahibuccus; Ansam Al-Habib; Stanley Okolo
Journal:  J Obstet Gynaecol India       Date:  2016-05-20

7.  Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterine insemination with controlled ovarian hyperstimulation.

Authors:  A J Bensdorp; R I Tjon-Kon-Fat; P M M Bossuyt; C A M Koks; G J E Oosterhuis; A Hoek; P G A Hompes; F J M Broekmans; H R Verhoeve; J P de Bruin; R van Golde; S Repping; B J Cohlen; M D A Lambers; P F van Bommel; E Slappendel; D Perquin; J M Smeenk; M J Pelinck; J Gianotten; D A Hoozemans; J W M Maas; M J C Eijkemans; F van der Veen; B W J Mol; M van Wely
Journal:  BMJ       Date:  2015-01-09

8.  Prognostic factors in intrauterine insemination cycles.

Authors:  Fernanda Sicchieri; Aline Bomfim Silva; Ana Carolina Japur de Sá Rosa E Silva; Paula Andrea de Albuquerque Sales Navarro; Rui Alberto Ferriani; Rosana Maria Dos Reis
Journal:  JBRA Assist Reprod       Date:  2018-03-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.